Animal Growth Promoters and Performance Enhancers Market - Global Forecast to 2026

Table of Content

---

"1    INTRODUCTION    26
1.1    OBJECTIVES OF THE STUDY    26
1.2    MARKET DEFINITION    27
1.2.1    INCLUSIONS AND EXCLUSIONS    27
1.3    MARKET SCOPE    28
1.3.1    MARKETS COVERED    28
FIGURE 1    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET SEGMENTATION    28
FIGURE 2    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY REGION    29
1.4    YEARS CONSIDERED FOR THE STUDY    29
1.5    CURRENCY    30
TABLE 1    STANDARD CURRENCY CONVERSION RATES    30
1.6    LIMITATIONS    30
1.7    STAKEHOLDERS    31
1.8    SUMMARY OF CHANGES    31
2    RESEARCH METHODOLOGY    33
2.1    RESEARCH DATA    33
FIGURE 3    RESEARCH DESIGN    33
2.1.1    SECONDARY DATA    34
2.1.1.1    Key data from secondary sources    35
2.1.2    PRIMARY DATA    36
FIGURE 4    PRIMARY SOURCES    36
2.1.2.1    Key data from primary sources    37
2.1.2.2    Key industry insights    38
FIGURE 5    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS    38
FIGURE 6    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION    39
2.2    MARKET SIZE ESTIMATION    39
FIGURE 7    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS    40
FIGURE 8    REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V.    40
FIGURE 9    SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)    41
FIGURE 10    DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR    42
FIGURE 11    CAGR PROJECTIONS    42
FIGURE 12    TOP-DOWN APPROACH    43

2.3    MARKET BREAKDOWN & DATA TRIANGULATION    44
FIGURE 13    MARKET DATA TRIANGULATION METHODOLOGY    44
2.4    MARKET SHARE ESTIMATION    45
2.5    ASSUMPTIONS FOR THE STUDY    45
2.6    RISK ASSESSMENT    46
3    EXECUTIVE SUMMARY    47
FIGURE 14    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)    47
FIGURE 15    NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)    48
FIGURE 16    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)    48
FIGURE 17    GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET    49
4    PREMIUM INSIGHTS    50
4.1    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW    50
FIGURE 18    CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH    50
4.2    ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020)    51
FIGURE 19    NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020    51
4.3    GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    52
FIGURE 20    EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING
THE FORECAST PERIOD    52
4.4    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
REGIONAL MIX    53
FIGURE 21    ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    53
5    MARKET OVERVIEW    54
5.1    INTRODUCTION    54
5.2    MARKET DYNAMICS    54
FIGURE 22    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    54
5.2.1    DRIVERS    55
5.2.1.1    Increase in demand and consumption of livestock-based products    55
TABLE 2    PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS    55
FIGURE 23    ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)    56
FIGURE 24    ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)    56
5.2.1.2    Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters    57
5.2.1.3    Rise in the global demand for naturally produced growth promoters    58
5.2.1.4    Rise in awareness about growth promoters    58
FIGURE 25    US: ANTIBIOTICS SALES (2018)    58
5.2.1.5    Rise in animal epidemics and climate change    59
5.2.2    RESTRAINTS    60
5.2.2.1    Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals    60
5.2.2.2    Ban on antibiotics in different nations    60
TABLE 3    BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR    61
5.2.3    OPPORTUNITIES    61
5.2.3.1    Focus on increasing environmental sustainability    61
5.2.4    CHALLENGES    62
5.2.4.1    Increasing global feed tonnage and high feed costs
leading to the adoption of conventional feeding systems    62
5.2.4.2    Growing threat of disease transmission to and from agricultural animals    63
6    INDUSTRY INSIGHTS    64
6.1    INDUSTRY TRENDS    64
6.1.1    INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    64
TABLE 4    INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS    64
6.1.2    GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY    64
TABLE 5    MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019)    65
6.2    PRICING ANALYSIS    65
TABLE 6    AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS    65
TABLE 7    SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP)    66
6.3    VALUE CHAIN ANALYSIS    66
FIGURE 26    VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    67
6.4    ECOSYSTEM MAPPING    67
FIGURE 27    ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    68
6.5    SUPPLY CHAIN ANALYSIS    68
FIGURE 28    SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    69
6.6    PORTER’S FIVE FORCES ANALYSIS    70
TABLE 8    PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020)    70
6.6.1    INTENSITY OF COMPETITIVE RIVALRY    70
6.6.2    BARGAINING POWER OF SUPPLIERS    70
6.6.3    BARGAINING POWER OF BUYERS    71
6.6.4    THREAT OF NEW ENTRANTS    71
6.6.5    THREAT OF SUBSTITUTES    71
6.7    REGULATORY ANALYSIS    72
FIGURE 29    DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    74
FIGURE 30    APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE    75
6.8    PATENT ANALYSIS    76
6.8.1    PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    76
FIGURE 31    GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015–2020    76
6.9    TRADE ANALYSIS    77
TABLE 9    IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS    77
6.10    IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    77
7    ANIMAL GROWTH PROMOTERS AND PERFORMANCE
ENHANCERS MARKET, BY TYPE    79
7.1    INTRODUCTION    80
TABLE 10    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    80
7.2    NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    80
TABLE 11    NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    80
TABLE 12    NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    81
7.2.1    PREBIOTICS & PROBIOTICS    81
7.2.1.1    Prebiotics & probiotics hold the largest share of the market    81
TABLE 13    PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    82
7.2.2    ACIDIFIERS    83
7.2.2.1    Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers    83
TABLE 14    ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    84
7.2.3    PHYTOGENICS    84
7.2.3.1    Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics    84
TABLE 15    PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    85
7.2.4    FEED ENZYMES    85
7.2.4.1    Feed enzymes segment to benefit from the bans on antibiotics and hormones    85

TABLE 16    FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    86
7.2.5    HORMONES    86
7.2.5.1    Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment    86
TABLE 17    HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    87
7.2.6    OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    88
TABLE 18    OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    89
7.3    ANTIBIOTIC GROWTH PROMOTERS    89
7.3.1    ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS    89
TABLE 19    PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019)    90
TABLE 20    ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY    91
TABLE 21    ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    92
8    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE    93
8.1    INTRODUCTION    94
TABLE 22    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    94
8.2    POULTRY    94
8.2.1    THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020    94
TABLE 23    IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020)    95
TABLE 24    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)    96
8.3    LIVESTOCK    96
8.3.1    THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD    96
TABLE 25    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION)    97
8.4    SWINE    98
8.4.1    RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS    98
TABLE 26    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)    99
8.5    AQUATIC ANIMALS    99
8.5.1    GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS    99
TABLE 27    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)    100

8.6    OTHER ANIMALS    100
TABLE 28    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)    101
9    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION    102
9.1    INTRODUCTION    103
FIGURE 32    ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD    103
TABLE 29    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019–2026 (USD MILLION)    104
9.2    ASIA PACIFIC    105
FIGURE 33    ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT    105
TABLE 30    ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    106
TABLE 31    ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    106
TABLE 32    ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    107
TABLE 33    ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    107
9.2.1    CHINA    108
9.2.1.1    China to dominate the APAC animal growth promoters and performance enhancers market    108
TABLE 34    CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    108
TABLE 35    CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    109
TABLE 36    CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    109
9.2.2    INDIA    110
9.2.2.1    Large livestock population and increased production and export capacities to drive market growth    110
TABLE 37    INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    110
TABLE 38    INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    111
TABLE 39    INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    111
9.2.3    JAPAN    112
9.2.3.1    Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan    112
TABLE 40    JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    112
TABLE 41    JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    113
TABLE 42    JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    113
9.2.4    AUSTRALIA    114
9.2.4.1    Large cattle population and heavy meat exports to support the market in Australia    114
TABLE 43    AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    114
TABLE 44    AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    115
TABLE 45    AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    115
9.2.5    REST OF ASIA PACIFIC    116
9.2.5.1    Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC    116
TABLE 46    REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY    116
TABLE 47    ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    116
TABLE 48    ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    117
TABLE 49    ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    117
9.3    NORTH AMERICA    118
TABLE 50    NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    118
TABLE 51    NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    118
TABLE 52    NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    119
TABLE 53    NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    119
9.3.1    US    120
9.3.1.1    Increasing meat consumption to drive the market in the US    120
FIGURE 34    US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS)    120
TABLE 54    US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    121
TABLE 55    US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    121
TABLE 56    US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    122
9.3.2    CANADA    122
9.3.2.1    Production and export of meat and aquaculture in Canada to drive the market growth    122
TABLE 57    BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019    123
TABLE 58    CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    123
TABLE 59    CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    124
TABLE 60    CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    124
9.4    EUROPE    125
FIGURE 35    EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT    125
TABLE 61    EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    126
TABLE 62    EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    126
TABLE 63    EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    126
TABLE 64    EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    127
9.4.1    UK    127
9.4.1.1    Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK    127
TABLE 65    UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    128
TABLE 66    UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    128
TABLE 67    UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    128
9.4.2    GERMANY    129
9.4.2.1    Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany    129
FIGURE 36    SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018)    129
TABLE 68    GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    130
TABLE 69    GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    130
TABLE 70    GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    130
9.4.3    SWITZERLAND    131
9.4.3.1    Increasing milk demand to drive the market in Switzerland    131
TABLE 71    SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    131
TABLE 72    SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    131
TABLE 73    SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    132
9.4.4    RUSSIA    132
9.4.4.1    Russia to hold the largest share of the European market due to its large poultry production    132
TABLE 74    RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    133
TABLE 75    RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    133
TABLE 76    RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    133
9.4.5    REST OF EUROPE    134
9.4.5.1    Technological advancements and the strong trade industry to support the RoE market    134
TABLE 77    ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    134
TABLE 78    ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    135
TABLE 79    ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    135
9.5    LATIN AMERICA    136
TABLE 80    LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    136
TABLE 81    LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    136
TABLE 82    LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    136
TABLE 83    LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    137
9.5.1    BRAZIL    137
9.5.1.1    Brazil to dominate the Latin American market for animal growth promoters and performance enhancers    137
TABLE 84    BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    137
TABLE 85    BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    138
TABLE 86    BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    138
9.5.2    REST OF LATIN AMERICA    138
9.5.2.1    Strong demand for animal products and support initiatives to help the market in the RoLA    138
TABLE 87    ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    139
TABLE 88    ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    139
TABLE 89    ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    140
9.6    MIDDLE EAST    140
9.6.1    INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST    140
TABLE 90    MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    140
TABLE 91    MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    141
TABLE 92    MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    141

9.7    AFRICA    141
9.7.1    RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA    141
TABLE 93    AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    142
TABLE 94    AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION)    142
TABLE 95    AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)    143
10    COMPETITIVE LANDSCAPE    144
10.1    INTRODUCTION    144
FIGURE 37    KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)    144
10.2    REVENUE ANALYSIS OF KEY MARKET PLAYERS    145
FIGURE 38    REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET    145
10.3    MARKET SHARE ANALYSIS    145
FIGURE 39    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020    146
10.4    COMPETITIVE SCENARIO    147
10.4.1    PRODUCT LAUNCHES    147
TABLE 96    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021)    147
10.4.2    DEALS    148
TABLE 97    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021)    148
10.4.3    OTHER DEVELOPMENTS    149
TABLE 98    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021)    149
10.5    COMPETITIVE BENCHMARKING    150
10.5.1    COMPANY FOOTPRINT FOR KEY PLAYERS    150
10.5.2    PRODUCT TYPE FOOTPRINT OF COMPANIES    151
10.5.3    ANIMAL TYPE FOOTPRINT OF COMPANIES    152
10.5.4    REGIONAL FOOTPRINT OF COMPANIES    153
10.6    GEOGRAPHIC FOOTPRINT OF COMPANIES    154
10.6.1    GEOGRAPHIC REVENUE MIX: KEY PLAYERS    154
10.7    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
R&D EXPENDITURE    155
10.7.1    R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020)    155
10.8    COMPANY EVALUATION MATRIX    155
10.8.1    STARS    156
10.8.2    EMERGING LEADERS    156
10.8.3    PERVASIVE PLAYERS    156
10.8.4    EMERGING COMPANIES    156
FIGURE 40    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX    157
10.9    COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)    158
10.9.1    PROGRESSIVE COMPANIES    158
10.9.2    STARTING BLOCKS    158
10.9.3    RESPONSIVE COMPANIES    158
10.9.4    DYNAMIC COMPANIES    158
FIGURE 41    ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS    159
11    COMPANY PROFILES    160
11.1    KEY PLAYERS    160
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1    CARGILL, INCORPORATED    160
TABLE 99    CARGILL, INCORPORATED: BUSINESS OVERVIEW    160
11.1.2    ROYAL DSM N.V.    165
TABLE 100    ROYAL DSM N.V.: BUSINESS OVERVIEW    165
FIGURE 42    COMPANY SNAPSHOT: ROYAL DSM N.V. (2020)    166
11.1.3    ELANCO ANIMAL HEALTH INCORPORATED    170
TABLE 101    ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW    170
FIGURE 43    COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020)    171
11.1.4    BOEHRINGER INGELHEIM GROUP    174
TABLE 102    BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW    174
FIGURE 44    COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020)    175
11.1.5    MERCK & CO., INC.    178
TABLE 103    MERCK & CO., INC.: BUSINESS OVERVIEW    178
FIGURE 45    COMPANY SNAPSHOT: MERCK & CO., INC. (2020)    179
11.1.6    ARCHER-DANIELS-MIDLAND COMPANY (ADM)    182
TABLE 104    ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW    182
FIGURE 46    COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020)    183
11.1.7    BLUESTAR ADISSEO COMPANY    188
TABLE 105    BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW    188
FIGURE 47    COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020)    189
11.1.8    ALLTECH CORPORATION    191
TABLE 106    ALLTECH CORPORATION: BUSINESS OVERVIEW    191
11.1.9    EVONIK INDUSTRIES AG    194
TABLE 107    EVONIK INDUSTRIES AG: BUSINESS OVERVIEW    194
FIGURE 48    COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020)    195
11.1.10    VETOQUINOL S.A.    197
TABLE 108    VETOQUINOL S.A.: BUSINESS OVERVIEW    197

11.2    OTHER PLAYERS    200
11.2.1    BUPO ANIMAL HEALTH PTY LTD.    200
TABLE 109    BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW    200
11.2.2    NOVUS INTERNATIONAL, INC.    202
TABLE 110    NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW    202
11.2.3    ASSOCIATED BRITISH FOODS PLC    205
TABLE 111    ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW    205
FIGURE 49    COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020)    206
11.2.4    ERBER AG    208
TABLE 112    ERBER AG: BUSINESS OVERVIEW    208
11.2.5    PHIBRO ANIMAL HEALTH CORPORATION    211
TABLE 113    PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW    211
FIGURE 50    COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020)    212
11.2.6    KEMIN INDUSTRIES, INC.    215
TABLE 114    KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW    215
11.2.7    ZOETIS INC.    219
TABLE 115    ZOETIS INC.: BUSINESS OVERVIEW    219
FIGURE 51    COMPANY SNAPSHOT: ZOETIS INC. (2020)    220
11.2.8    NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP)    222
TABLE 116    NUTRECO N.V.: BUSINESS OVERVIEW    222
FIGURE 52    COMPANY SNAPSHOT: SHV GROUP (2020)    223
11.2.9    NOVOZYMES A/S    226
TABLE 117    NOVOZYMES A/S.: BUSINESS OVERVIEW    226
FIGURE 53    COMPANY SNAPSHOT: NOVOZYMES A/S (2020)    227
11.2.10    BASF SE    229
TABLE 118    BASF SE: BUSINESS OVERVIEW    229
FIGURE 54    COMPANY SNAPSHOT: BASF SE (2020)    230
11.2.11    LAND O’LAKES, INC.    232
11.2.12    CHR. HANSEN A/S    233
11.2.13    BIOMIN HOLDING GMBH    234
11.2.14    GUANGDONG VTR BIO-TECH CO., LTD.    235
11.2.15    LALLEMAND INC.    236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12    APPENDIX    237
12.1    DISCUSSION GUIDE    237
12.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    243
12.3    AVAILABLE CUSTOMIZATIONS    245
12.4    RELATED REPORTS    245
12.5    AUTHOR DETAILS    246"